Here's the live share price of Dr. Lal Pathlabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Dr. Lal Pathlabs has gained 6.70% CAGR. Over the past year, the corresponding return has been 0.80%.
Dr. Lal Pathlabs’s current P/E of 51.20x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Dr. Lal Pathlabs | 3.01 | -0.95 | -0.43 | 12.12 | 0.80 | 6.93 | 6.70 |
| Max Healthcare Institute | -3.10 | 3.14 | -7.75 | 5.22 | 12.87 | 36.03 | 60.71 |
| Apollo Hospitals Enterprise | -1.99 | 3.19 | 2.47 | 10.40 | 9.38 | 19.34 | 29.97 |
| Fortis Healthcare | -1.14 | 3.59 | 19.54 | 51.19 | 63.71 | 54.64 | 51.62 |
| Narayana Hrudayalaya | 1.30 | 1.26 | -8.41 | -0.30 | 37.93 | 30.44 | 39.83 |
| Global Health | -2.46 | 0.59 | 0.24 | 9.17 | 18.85 | 46.77 | 25.88 |
| Aster DM Healthcare | -4.05 | 7.46 | 12.03 | 33.17 | 52.61 | 39.94 | 38.27 |
| Krishna Institute of Medical Sciences | 0.51 | 5.28 | -3.57 | 9.77 | 32.88 | 34.50 | 29.43 |
| Dr. Agarwals Health Care | -0.87 | 2.48 | 12.87 | 46.28 | 28.66 | 8.76 | 5.17 |
| Rainbow Childrens Medicare | 0.27 | 1.81 | -10.17 | 0.61 | -15.08 | 25.72 | 24.92 |
| Healthcare Global Enterprises | -1.23 | 15.21 | 20.42 | 30.85 | 66.59 | 37.56 | 44.23 |
| Jupiter Life Line Hospitals | 4.97 | 5.89 | 10.75 | 8.69 | 17.74 | 13.83 | 8.08 |
| Metropolis Healthcare | 3.42 | -3.13 | -1.07 | 16.81 | -7.88 | 5.33 | 0.24 |
| Vijaya Diagnostic Centre | 0.12 | -1.26 | -7.98 | -0.87 | -0.71 | 31.33 | 9.84 |
| Yatharth Hospital & Trauma Care Services | -0.03 | 6.39 | 23.62 | 69.30 | 20.94 | 33.72 | 19.05 |
| Thyrocare Technologies | 10.37 | 21.57 | 5.43 | 55.98 | 48.91 | 29.60 | 3.96 |
| Kovai Medical Center and Hospital | -4.26 | 2.32 | 2.44 | 20.49 | 17.24 | 62.34 | 55.22 |
| Indraprastha Medical Corporation | 10.95 | 32.45 | 28.41 | 53.20 | 48.12 | 104.27 | 65.46 |
| Artemis Medicare Services | 1.31 | 5.71 | 3.89 | -4.78 | -10.88 | 51.58 | 72.07 |
| Shalby | -1.95 | -9.07 | 14.94 | 28.47 | 1.78 | 20.25 | 21.37 |
Over the last one year, Dr. Lal Pathlabs has gained 0.80% compared to peers like Max Healthcare Institute (12.87%), Apollo Hospitals Enterprise (9.38%), Fortis Healthcare (63.71%). From a 5 year perspective, Dr. Lal Pathlabs has underperformed peers relative to Max Healthcare Institute (60.71%) and Apollo Hospitals Enterprise (29.97%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 3,096.72 | 3,095.05 |
| 10 | 3,118.76 | 3,106.18 |
| 20 | 3,126.4 | 3,132.23 |
| 50 | 3,237.77 | 3,158.05 |
| 100 | 3,103.58 | 3,102.92 |
| 200 | 2,901.3 | 3,011.3 |
In the latest quarter, Dr. Lal Pathlabs saw a drop in promoter holding to 53.22%, while DII stake increased to 18.49%, FII holding rose to 21.86%, and public shareholding moved down to 6.07% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 20,00,000 | 0.73 | 623.62 | |
| 12,00,722 | 1.49 | 374.4 | |
| 8,23,007 | 1.1 | 256.62 | |
| 6,50,000 | 0.59 | 202.68 | |
| 6,45,485 | 0.3 | 201.27 | |
| 6,09,112 | 2.34 | 189.93 | |
| 5,70,000 | 1.07 | 177.73 | |
| 5,12,777 | 1.27 | 159.89 | |
| 3,90,563 | 1.04 | 121.78 | |
| 3,88,808 | 1.07 | 121.23 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Nov 01, 2025, 2:49 PM IST | Dr. Lal Pathlabs Ltd - Receipt Of An Assessment Order And Demand Notice Issued By Income Tax Department |
| Nov 01, 2025, 12:27 AM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 31, 2025, 8:06 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 31, 2025, 8:05 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 31, 2025, 7:59 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation |
Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388. Currently Company is involved in the business activities of Other human health activities. Company's Total Operating Revenue is Rs. 2351.62 Cr. and Equity Capital is Rs. 83.59 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Lal Pathlabs is ₹3,136.10 as on Oct 31, 2025.
The Dr. Lal Pathlabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Dr. Lal Pathlabs is ₹26,272.84 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Dr. Lal Pathlabs are ₹3,210.20 and ₹3,064.00.
The 52-week high/low is the highest and lowest price at which Dr. Lal Pathlabs stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Lal Pathlabs is ₹3,542.60 and 52-week low of Dr. Lal Pathlabs is ₹2,295.10 as on Oct 31, 2025.
The Dr. Lal Pathlabs has shown returns of 1.52% over the past day, -0.95% for the past month, -0.43% over 3 months, 0.8% over 1 year, 6.93% across 3 years, and 6.7% over 5 years.
P/E ratio of and PB ratio of Dr. Lal Pathlabs are 51.20 and 13.12 on Oct 31, 2025. While the company gives a dividend yield of 0.77 per annum.